Physiogenex will be presenting a poster on Tuesday, November 5th, 2019 from 12pm to 1:30pm at the Obesity Week 2019 (November 3-7) in Las Vegas.
Dr François Briand, our Director of Research and Development, will be at the Poster Session at Mandalay Bay South Convention Center, Shoreline Exhibit Hall, presenting “Lorcaserin Has Less Metabolic Benefits Than Liraglutide in Free Choice Diet-Induced Obese Rats”.
Feel free to contact us if you wish to meet Dr. Briand and/or discuss your drug development projects with us.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.